23 results
8-K
RGBP
Regen BioPharma Inc
2 Jul 21
Other Events
2:04pm
augmentation of NR2F6 inhibition to augment T-cell activation.
The NR2F6 nuclear receptor has been identified as a potentially very important immune
8-K
RGBP
Regen BioPharma Inc
6 Jul 18
Other Events
2:58pm
” The abovementioned application relates to agonists and antagonists of nuclear receptor activity, specifically to the modulation ofNR2F6 activity and NR2F6
8-K
RGBP
Regen BioPharma Inc
6 Jan 15
Other Events
12:00am
United States Patent Application No. 14588373 pertaining to the suppression of the nuclear receptor NR2F2 using compositions that induce RNA interference
8-K
RGBP
Regen BioPharma Inc
13 Jul 21
Other Events
2:00pm
of screening test compounds to identifying agonists and antagonists of the orphan nuclear receptor NR2F6 by measuring the ability of a test compound
424B3
ut7db a1ds4g
20 Nov 23
Prospectus supplement
9:38am
424B3
z940owv3tdr5wm
15 May 23
Prospectus supplement
10:25am
424B3
d2fgje0p9rm
2 Oct 23
Prospectus supplement
1:42pm